This study concluded that CD103+ has a potent regulatory effect on EMT through the guidance of CSC exosomes to target distant organs and other cancer cells, assigning the higher metastatic capacity of ccRCC to lungs and pointing to CD103+ exosomes as a potential metastatic diagnostic biomarker [171]. The gene discussed is ITGAE; the disease is nonpapillary renal cell carcinoma.